@article {18580, title = {The Crosstalk between Tissue Engineering and Pharmaceutical Biotechnology: Recent Advances and Future Directions}, journal = {Advances in Pharmaceutical Biotechnology}, volume = {16}, year = {2015}, month = {2015-08-20 00:00:00}, pages = {1012-1023}, publisher = {Bentham Science}, abstract = {

Tissue-engineered constructs made of biotechnology-derived materials have been preferred\ due to their chemical and physical composition, which offers both high versatility and a support to enclose/incorporate relevant signaling molecules and/or genes known to therapeutically induce tissue repair. Herein, a critical overview of the impact of different biotechnology-derived materials, scaffolds,\ and recombinant signaling molecules over the behavior of cells, another element of tissue engineered\ constructs, as well its regulatory role in tissue regeneration and disease progression is given. Additionally, these tissue-engineered constructs evolved to three-dimensional (3D) tissue-like models that, as an advancement of two-dimensional standard culture methods, are expected to be a valuable tool in the field of drug discovery and pharmaceutical research. Despite the improved design and conception of current proposed 3D tissue-like models, advanced control systems to enable and accelerate streamlining and automation of the numerous labor-intensive steps intrinsic to the development of tissue-engineered constructs are still to be achieved. In this sense, this review intends to present the biotechnology-derived materials that are being explored in the field of tissue engineering to generate 3D tissue-analogues and briefly highlight their foremost breakthroughs in tissue regeneration and drug discovery. It also aims to reinforce that the crosstalk between tissue engineering and pharmaceutical biotechnology has been fostering the outcomes of tissue engineering approaches through the use of biotechnology-derived signaling molecules. Gene delivery/therapy is also discussed as a forefront area that represents another cross point between tissue engineering and pharmaceutical biotechnology, in which nucleic acids can be considered a {\textquotedblleft}super pharmaceutical{\textquotedblright} to drive biological responses, including tissue regeneration.\ 

}, keywords = {3D tissue-like models, pharmaceutical biotechnology, Tissue engineering, tissue-engineered constructs}, issn = {1389-2010}, doi = {10.2174/1389201016666150826120257$\#$sthash.iRWcjU4u.dpuf}, url = {http://www.eurekaselect.com/134372/article}, author = {Pacheco, D. P. and Reis, R. L. and Correlo, V. M. and Marques, A. P.}, editor = {Silva, C. S. and Lopes, C. M. and Lobo, J. M. S. and Amaral, M. H.} }